Lewis T. Williams

Dr. Williams, Co-Founder, Chairman and CEO of Walking Fish Therapeutics and a Venture Partner at Quan Capital, has served as a member of our board of directors since June 2017. He founded Five Prime Therapeutics, Inc. in December 2001 and served as Executive Chairman of the Board until 2012 and as President and Chief Executive Officer from August 2011 to December 2017. He is currently a member of the Five Prime Board of Directors. Previously, Dr. Williams spent seven years at Chiron Corporation, now Novartis Vaccines and Diagnostics, Inc., most recently as Chief Scientific Officer. He also served on Chiron’s board of directors from 1999 to 2001. Prior to joining Chiron, Dr. Williams was a professor of medicine at the University of California, San Francisco and served as director of the University’s Cardiovascular Research Institution and Daiichi Research Center. Dr. Williams also has served on the faculties of Harvard Medical School and Massachusetts General Hospital and co-founded COR Therapeutics, Inc., a biotechnology company focused on cardiovascular disease. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Dr. Williams was previously a member of the boards of directors of COR Therapeutics, Inc. and Beckman Coulter, Inc., each of which was a public company. Dr. Williams received a B.S. from Rice University and an M.D. and a Ph.D. from Duke University.